Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non ...

Alzamend Neuro will begin its first Phase 2 trial of AL001 in 2025, using advanced imaging to study lithium distribution and ...

The "AI in Life Science Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been ...

Nano-X Imaging shares were up 10%, to $6.61, after the company said it has received CE mark certification to market its multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud ...

Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

Some medieval laws and punishments seem quite shocking by today’s standards and justice during the period was certainly not ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

Q4 2024 Earnings Call Transcript February 24, 2025 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.07. Operator: Good morning, and ...

Some health experts have call for further investigation, as figures show 82 deaths with suspected links to slimming drugs ...

November 2025 in - Guiding theme “Touch Smart Efficiency” - Opportunities for digitalization on the farm - Challenges: system ...

Here’s everything you need to know about Islam’s ‘Festival of Sacrifice’, including the London events confirmed so far ...